segunda-feira, fevereiro 14, 2005
Três farmacêuticas nas 10 piores empresas mundias
The Multinational Monitor, by Russell Mokhiber and Robert Weissman
ABBOTT LABORATORIES: DRUG PRICING CHUTZPAH
Chutzpah. Webster’s defines the Yiddish term now incorporated into English slang as: 1. unmitigated effrontery or impudence; gall. 2. audacity; nerve.
In the next edition, they may want to add: 3. See Abbott.
In December 2003, the company raised the U.S. price of its anti-AIDS drug Norvir (generic name ritanovir) by 400 percent. That is, unless the product is used in conjunction with other Abbott products — in which case the price increase is zero.
GLAXOSMITHKLINE: DEADLY DEPRESSING
GlaxoSmithKline, Paxil and selective serotonin reuptake inhibitors (SSRIs). It was the story that foreshadowed and strikingly paralleled the controversy surrounding Merck, Vioxx and Cox-2 inhibitors.
MERCK: 55,000 DEAD
It’s not as if people in power didn’t know about the impending disaster — what David Graham, a Food and Drug Administration (FDA) drug safety official, calls “maybe the single greatest drug-safety catastrophe in the history of this country.’’
Testifying before a Senate committee in November, Dr. Graham put the number in United States who had suffered heart attacks or stroke as result of taking the arthritis drug Vioxx in the range of 88,000 to 139,000.